Ulipristal Acetate Interferes With Actin Remodeling Induced by 17β-Estradiol and Progesterone in Human Endometrial Stromal Cells
Ulipristal acetate (UPA) is a selective progesterone receptor modulator (SPRM) used for emergency contraception and for the medical management of symptomatic uterine fibroids (UF). Treatment with UPA turns in amenorrhea and UF volume reduction. Treatment with UPA is associated with the frequent deve...
Main Authors: | Jorge E. Shortrede, Maria M. Montt-Guevara, Gisela Pennacchio, Michele Finiguerra, Andrea Giannini, Alessandro D. Genazzani, Tommaso Simoncini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00350/full |
Similar Items
-
Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma
by: Jae Ryoung Hwang, et al.
Published: (2023-12-01) -
[Immunohistochemical characteristic of myoma tissue in patients with uterine leiomyoma after treatment with ulipristal acetate]
by: Kuryk E.G., et al.
Published: (2015-09-01) -
Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells
by: Ranka Kanda, et al.
Published: (2022-01-01) -
Progesterone “against” progesterone. New links in the pathogenesis and future strategies in treatment of uterine fibroids
by: А. Н. Григоренко
Published: (2018-12-01) -
Estradiol and Progesterone as key modulators of central systems implicated in schizophrenia
by: A. Ruiz-Tristan, et al.
Published: (2022-06-01)